17 NOVEMBER 2020 21 COUNTRIES 20 CATEGORIES OLD BILLINGSGATE 5 REGIONS 500+ EXECUTIVES The European Lifestars Awards It forms a signature evening dinner are instrumental in highlighting the and networking function during incredible work being carried out the week of the Jefferies Annual across the life science value chain. Healthcare Conference in London. They are the only life science industry awards ceremony to celebrate not The prestigious ELAs combine a just the companies and individuals, champagne reception, 4-course but the countries and regions that dinner, evening entertainment, THE charity silent auction and post-show they represent. celebrations alongside the official 20 awards will be contested by 170+ ceremony. finalists representing 21 countries The ELAs are where the great and from the 5 regions of Europe. They E will be joined by hundreds of their the good of the sector recognise support network. and celebrate their collective EUROPEAN achievements. One region will also be crowned Region Champion on the night.

The awards ceremony is taking place on the evening of the 17th November 2020 at the Victorian Grade II listed Old Billingsgate on the North Bank of LIFESTARS the in Central London. AWARDS

The annual, European Lifestars Awards (ELAs) bring together hundreds of European life science leaders, investors, partners and deal makers. It is a L celebration of the success stories, breakthroughs, transactions and transformational deals and the people, teams and organisations that have played a critical role in the advancement of the industry over a 12 month period.

PARTNERS AINVENTING FOR LIFE 17NOV20 20 hotly contested award categories have been chosen to help shine a light on the breadth and depth of breakthroughs, transactions and deal 20making that have taken place during the 12-month qualifying period.

AWARD The categories acknowledge and celebrate the achievements of fledgling life science start-ups all the way through to Pharma giants, and everyone in between. There will be an individual Winner and a Highly Commended in each category. CATEGORIES

1. Pre-Seed Finance Raise of the Year 11. Deal of the Year (<£500m) 2. Seed-Stage Finance Raise of the Year 12. Deal of the Year (>£500m) 3. Series A Finance Raise of the Year 13. M&A Deal of the Year 4. Series B Finance Raise of the Year 14. Pharma BD Team of the Year 5. Series C (& beyond) Finance Raise of the Year 15. Biotech Company of the Year 6. IPO of the Year 16. Medtech Company of the Year 7. Post-IPO Equity Raise of the Year 17. Healthtech Company of the Year 8. Debt Finance Raise of the Year 18. Pharma Company of the Year 9. Venture Capital Firm of the Year 19. Private Company CEO of the Year 10. Corporate Venture Firm of the Year 20. Public Company CEO of the Year CATEGORIES COUNTRIES vote, willdetermine the2020 Region Champion. that, talliedthroughout theevening and,combined withthepublic representative region willcarryapointsscoring anditisthesepoints The finishing positionofeachindividualfinalist, andhence their their region group. of theindividualfinalist roster willdictate the geographical makeup of Countries are notguaranteed anequalnumberoffinalists, the strength night from itsconstituent countries. similar industry demographic. Eachregion willhave 34finalists onthe finalists in eachofthe20 Award categories andinallcasesshare a Each region isallocated countries that have theabilityto support ELIGIBLE COUNTRIES ceremony. Award at theendofformal contest the2020 Region Champion place in1of5regions. Eachregion will eligible to take partwillbeallocated a highly commended, the21countries Aside from theindividualwinnersand categories. and individualscontesting the addition to thecompanies demographic ofthefinalists, in celebrate theregional industry industry awards ceremony to (ELAs) are theonlylife science The European Lifestars Awards UK &IRELAND NORDICS MEDITERRANEAN DACH BENELUX IRELAND IRELAND SWEDEN |NORWAY ICELAND DENMARK |FINLAND SPAIN |PORTUGAL FRANCE |ISRAELITALY SWITZERLAND GERMANY |AUSTRIA THE NETHERLANDS BELGIUM |LUXEMBOURG

PROCESS ------NOMINATIONS1 JANUARY OPEN LIFESTARS CEREMONY AWARDS -RESULTS17 NOVEMBER EXCLUSIVELY AT RELEASED THEEUROPEAN 19 OCTOBER ISOPENEDFOR -APUBLICVOTE APERIODOF 72HRS 12 OCTOBER -JUDGINGCOMMITTEE FINALVOTING -JUDGINGCOMMITTEE25 AUGUST CONVENE -JUDGINGCOMMITTEE15 AUGUST CONVENE -NOMINATIONS11 AUGUST CLOSE 1 FEBRUARY -JUDGINGCOMMITTEE SELECTIONBEGINS PROCESS AWARDS ------word supportingdocumentinamaximumof2categories. Entriesare free. Entrants are invited to complete ashortonlinenomination form, includinga400- scores willbecombined to produce theRegion Champion. A weighting of20%willbeallocated to thepublicvote outcome. These andthejudges The scores are usedto order thefinishingpositionsofeachfinalist intheir categories. Committee engageinasecond andfinal round of voting providing scores for eachfinalist The 170+ finalist roster is released publiclyviatraditional andsocialmediachannels. that represents eachofthefive regions. Committee engageinafirst round of validation ofentrants creating afinalist roster Solicited andjudgingcommittee nominations are closedto entry, collated andvalidated. entries. The committee are invited to provide theirown nominations to accompany solicited corporate partners. The international judgingcommittee isformed from key industry stakeholders and

JUDGING - - - If you would like to enquire aboutjoiningthejudging faculty click [email protected] 12OCTOBER -19OCTOBER BETWEEN -25AUGUST 15AUGUST BETWEEN 1FEBRUARY -11AUGUST BETWEEN - - - Committee engageinasecond andfinal round of voting providing scores for eachfinalist. that represents eachofthefive regions. Committee engageinafirst round ofinitial validation ofentrants creating afinalist roster Judges selecttheircategories for review andsubmittheirown entriesacross their regions. and voting to generate thisyear’s finalists and to selectthewinners. Members ofthefaculty participate intwo rounds of submission review JUDGING COMMITTEE Firms andkey stakeholders. services, contract services, PRandIR law firms,professional andfinancial investors, pharma,globaladvisory, geographically diverse poolofleading They are selected from a their cross-border knowledge. industry experience andstrength of Awards are chosenfor their wealth of of the2020 European Lifestars The international judgingfaculty PRE-SEED SEED FINANCE RAISE FINANCE RAISE OF THE YEAR OF THE YEAR This award recognises a company that has successfully This award recognises a company that has successfully completed a significant, impactful or transformational private completed a significant, impactful or transformational fundraise at Pre-Seed-Stage level. private fundraise at Seed-Stage level.

It is open to private European life science companies only. It is open to private European life science companies only.

Qualifying Criteria Qualifying Criteria • Must be a fundraise by a private company • Must be a fundraise by a private company • Must have raised the funds in the period between 1 September • Must have raised the funds in the period between 1 September 2019 and 1 September 2020 2019 and 1 September 2020 • Must be a company with European headquarters • Must be a company with European headquarters

Judges Will Be Paying Particular Attention To: Judges Will Be Paying Particular Attention To: • Amount of funds raised • Amount of funds raised • Process / speed / allocation fulfilment of securing significant • Process / speed / allocation fulfilment of securing significant new funds new funds • Level / reputation of investors attracted • Level / reputation of investors attracted • Post-finance allocation / use of proceeds • Post-finance allocation / use of proceeds • Level of value creation / value realisation from raise • Level of value creation / value realisation from raise • Company research / technology focus and novelty / meeting • Company research / technology focus and novelty / meeting unmet need unmet need

SUBMIT ENTRY SUBMIT ENTRY AWARDS AWARDS SERIES A SERIES B FINANCE RAISE FINANCE RAISE OF THE YEAR OF THE YEAR This award recognises a company that has successfully This award recognises a company that has successfully completed a significant, impactful or transformational private completed a significant, impactful or transformational private fundraise at Series A level. fundraise at Series B level.

It is open to private European life science companies only. It is open to private European life science companies only.

Qualifying Criteria Qualifying Criteria • Must be a fundraise by a private company • Must be a fundraise by a private company • Must have raised the funds in the period between 1 September • Must have raised the funds in the period between 1 September 2019 and 1 September 2020 2019 and 1 September 2020 • Must be a company with European headquarters • Must be a company with European headquarters

Judges Will Be Paying Particular Attention To: Judges Will Be Paying Particular Attention To: • Amount of funds raised • Amount of funds raised • Process / speed / allocation fulfilment of securing significant • Process / speed / allocation fulfilment of securing significant new funds new funds • Level / reputation of investors attracted / reputation of • Level / reputation of investors attracted / reputation of investors reinvesting investors reinvesting • Post-finance allocation / use of proceeds • Post-finance allocation / use of proceeds • Level of value creation / value realisation from raise • Level of value creation / value realisation from raise

SUBMIT ENTRY SUBMIT ENTRY AWARDS AWARDS SERIES C & BEYOND FINANCE RAISE IPO OF THE YEAR OF THE YEAR This award recognises a company that has successfully This award recognises a company that has successfully completed a significant, impactful or transformational private completed a significant, impactful or transformational IPO fundraise at Series C or beyond level. on any exchange.

It is open to private European life science companies only. It is open to public European life science companies only.

Qualifying Criteria Qualifying Criteria • Must be a fundraise by a private company HOSTED BY: • Must be a public company • Must have raised the funds in the period between 1 September • Must have raised the funds in the period between 1 September 2019 and 1 September 2020 2019 to 1 September 2020 • Must be a company with European headquarters • Must be a company with a European headquarters • Must be an IPO (primary, up-listing or dual-listing) NOT a Judges Will Be Paying Particular Attention To: secondary placement or follow-on • Amount of funds raised • Process / speed / allocation fulfilment of securing significant Judges Will Be Paying Particular Attention To: new funds • Amount of funds raised • Level / reputation of investors attracted / reputation of • Process / speed / allocation fulfilment of securing significant investors reinvesting new funds • Post-finance allocation / use of proceeds • Level / reputation of new investor(s) attracted • Level of value creation / value realisation from raise • Post-finance allocation / use of proceeds • Level of value creation / value realisation from raise

SUBMIT ENTRY SUBMIT ENTRY AWARDS AWARDS DEBT POST-IPO EQUITY FINANCE RAISE RAISE OF THE YEAR OF THE YEAR This award recognises a company that has successfully completed This award recognises a European life science company a significant, impactful or transformational secondary placement or that has successfully completed a significant, impactful or follow-on equity raise (not debt) on any exchange. transformational debt financing.

It is open to public European life science companies only. It is open to public European life science companies only.

Qualifying Criteria Qualifying Criteria • Must be a public company • Must be a public company • Must have raised the funds in the period between 1 September • Must have raised the funds in the period between 1 September 2019 to 1 September 2020 2019 to 1 September 2020 • Must be a company with a European headquarters • Must be a company with a European headquarters • Raise must be a secondary placement or follow-on NOT an • Raise must be a debt raise not equity IPO, up-listing or dual-listing Judges Will Be Paying Particular Attention To: Judges Will Be Paying Particular Attention To: • Amount and type of funds raised • Amount and type of funds raised • Process / speed / allocation fulfilment of securing significant • Process / speed / allocation fulfilment of securing significant new funds new funds • Level / reputation of corporate lender attracted • Level / reputation of investor(s) attracted • Post-finance allocation / use of proceeds • Post-finance allocation / use of proceeds • Level of value creation / value realisation from raise • Level of value creation / value realisation from raise

SUBMIT ENTRY SUBMIT ENTRY AWARDS AWARDS CORPORATE VENTURE VENTURE CAPITAL FIRM / STRATEGIC FIRM OF THE YEAR INVESTOR OF THE YEAR This award recognises a European Venture Capital firm that This award recognises a European Corporate Venture Capital has outperformed peers, created value and demonstrated truly firm or strategic investor that has outperformed peers, created outstanding investment decision making. value and demonstrated truly outstanding investment decision making.

Qualifying Criteria Qualifying Criteria • Open to venture capital firms only • Open to corporate venture or strategic investors from pharma, • Firm must have more than 20% portfolio holdings in commercial leaders and big tech only healthcare and/or life sciences companies • Period to be judged review is between 1 September 2019 and 1 • Period to be judged review is between 1 September 2019 and 1 September 2020 September 2020 • Firms must have headquarters / offices in Europe • Firms must have headquarters in Europe Judges Will Be Paying Particular Attention To: Judges Will Be Paying Particular Attention To: • Evidence of innovative company creation and deal-making • Evidence of innovative company creation and deal-making strategies strategies • Volume and value of investments made in the qualifying timeline • Volume of investments made in the qualifying timeline • Number of lead investments made • Number of lead investments made • Number / quality of successful syndications • Number / quality of successful exits • Post-investment strategic earn-outs • Number / value of new funds raised • Fund performance and returns to LPs SUBMIT ENTRY

SUBMIT ENTRY AWARDS AWARDS DEAL OF THE DEAL OF THE YEAR (<£500M) YEAR (>£500M) This award recognises the teams and organisations who have This award recognises the teams and organisations who have executed a truly transformational and high value creating executed a truly transformational and high value creating deal for both the company and the wider industry. The deal for both the company and the wider industry. The deal could be a licensing agreement, co-development or a deal could be a licensing agreement, co-development or a creative alliance or partnership that unlocks significant value. creative alliance or partnership that unlocks significant value.

Qualifying Criteria Qualifying Criteria • Deal size must be less than £500m • Deal size must be equal to or greater than £500m • The lead company must be a European Life Science company • The lead company must be a European Life Science company • Open to private or public companies WITH peers, pharma, • Open to private or public companies WITH pharma, commercial leaders or big tech commercial leaders or big tech • Deal can be either a licensing deal, single asset acquisition or • Deal can be either a licensing deal, single asset acquisition or collaborative agreement involving a particular drug, project or collaborative agreement involving a particular drug, project or group of drugs/projects group of drugs/projects • A license, partnership or alliance between companies NOT • A license, partnership or alliance between companies NOT M&A M&A • Deal to have completed in the period between 1 September • Deal to have completed in the period between 1 September 2019 and 1 September 2020 2019 and 1 September 2020

Judges Will Be Paying Particular Attention To: Judges Will Be Paying Particular Attention To: • Uniqueness or novelty of deal strategy / terms and structure • Uniqueness or novelty of deal strategy / terms and structure • Level of value creation / size of deal (upfront, milestone and • Level of value creation / size of deal (upfront, milestone and total value) total value) • Strength of partner / partnership and deal teams • Strength of partner / partnership and deal teams • Potential game / industry changing implications within next • Potential game / industry changing implications within next 12-months 12-months • Post-deal performance • Post-deal performance

SUBMIT ENTRY SUBMIT ENTRY M&A DEAL OF PHARMA BD THE YEAR TEAM OF THE YEAR This award recognises the teams and organisations who have This award recognises the business development team from executed a truly transformational and high value M&A deal for a pharma or large cap biotech company that has excelled both the company and the wider industry. in sourcing, executing and delivering extraordinary and transformational deals that created significant value for consumers, company and shareholders.

Qualifying Criteria Qualifying Criteria • The lead company must be a European Life Science company • Open to all pharma companies and large cap large cap • Open to private, public companies, pharma, commercial biotech companies with a market capitalisation that is $10bn leaders or big tech or above. • Deal must be an M&A (including asset business unit) deal NOT • Open to all business development teams or cross-company a license, partnership or alliance teams on a specific deal/project • Deal to have completed in the period between 1 September • Criteria relates to the period between 1 September 2019 and 1 2019 and 1 September 2020 September 2020

Judges Will Be Paying Particular Attention To: Judges Will Be Paying Particular Attention To: • Uniqueness or novelty of deal strategy / terms and structure • Quality and volume of deals completed • Level of value creation / size of deal • Achievement of milestones and goals and the overcoming of obstacles • Strength of acquirers existing pipeline / synergy with existing portfolio • Uniqueness or novelty of deal strategies/terms and structure • Potential game / industry changing implications within next • Strength of team leadership and culture 12-months • How alignment across parties was achieved • Post-deal performance

SUBMIT ENTRY SUBMIT ENTRY AWARDS AWARDS BIOTECH OF MEDTECH OF THE YEAR THE YEAR This award recognises a European Biotech (drug discovery, pre- This award recognises a European Medtech (device, surgical, clinical, clinical, OTM therapeutic) company that has demonstrated diagnostic) company that has demonstrated superior excellence in a superior excellence in strategy, process, focus and execution to strategy, process, focus and execution to create significant value create significant value for patients, investors, employees and the for patients, investors, employees and the broader life science broader life science community. community.

Qualifying Criteria Qualifying Criteria HOSTED BY: HOSTED BY: • Open to all Biotech therapeutic companies with European • Open to all Medtech/Medical Device companies with Headquarters European Headquarters • Open to all Biotech companies companies with a market • Open to all Medtech/Medical Device companies with a market capitalisation that is $10bn or less. capitalisation that is $10bn or less. • Submission relates to activities achieved in the period • Submission relates to activities achieved in the period INVENTING FOR LIFE between 1 September 2019 and 1 September 2020 between 1 September 2019 and 1 September 2020

Judges Will Be Paying Particular Attention To: Judges Will Be Paying Particular Attention To: • Targeting of unmet medical need / use of innovative • Targeting of unmet medical need / use of innovative approaches to pipeline development approaches to product development • Pipeline progress through drug discovery / pre-clinical / • Pipeline progress through in-development / clinical stages / clinical stages / market approval market approval • Closure of fundraises and strategic financing rounds • Closure of fundraises and strategic financing rounds • Key stages of strategic development / partnerships • Key stages of strategic development / partnerships • Implementation of new technologies, processes for strategic • Implementation of new technologies, processes for strategic advantage advantage

SUBMIT ENTRY SUBMIT ENTRY AWARDS AWARDS HEALTHTECH PHARMA OF OF THE YEAR THE YEAR This award recognises a European Healthtech (digital health, digital This award recognises a European Pharma or large-cap Biotech therapeutics, databases, applications and wearables) company that company that has demonstrated superior excellence in strategy, has demonstrated a superior excellence in strategy, process, focus process, focus and execution and contributed to the broader life and execution to create significant value for consumer, patients, science industry. investors, employees and the broader life science community.

Qualifying Criteria Qualifying Criteria • Open to all Healthtech companies with European Headquarters • Open to all pharma companies and large cap large cap biotech • Open to all Healthtech companies companies with a market companies with a market capitalisation that is $10bn or above. capitalisation that is $10bn or less. • Open to all pharma / large cap companies with European • Submission relates to activities achieved in the period between 1 Headquarters September 2019 and 1 September 2020 • Criteria relates to the period between 1 September 2019 and 1 September 2020 Judges Will Be Paying Particular Attention To: • Targeting of unmet medical need / use of innovative approaches to Judges Will Be Paying Particular Attention To: product development • Targeting of unmet medical need / use of innovative approaches • Pipeline progress through in-development / clinical stages / market to product development approval • Pipeline progress through in-development / clinical stages / • Closure of fundraises and strategic financing rounds market approval • Key stages of strategic development / partnerships • Closure of fundraises and strategic financing rounds • Implementation of new technologies, processes for strategic • Key stages of strategic development / partnerships advantage • Implementation of new technologies, processes for strategic advantage • Wider industry contribution and advocacy SUBMIT ENTRY

SUBMIT ENTRY AWARDS AWARDS PRIVATE COMPANY PUBLIC COMPANY CEO OF THE YEAR CEO OF THE YEAR This award recognises a private company CEO that has This award recognises a publicly-listed company CEO that has demonstrated truly outstanding and exemplary leadership in their demonstrated truly outstanding and exemplary leadership in their respective companies. respective companies.

Qualifying Criteria Qualifying Criteria • Open to CEOs of privately owned life science companies • Open to CEOs of publicly-listed life science companies • Period to be judged review is between 1 September 2019 and 1 • Period to be judged review is between 1 September 2019 and 1 September 2020 September 2020

Judges Will Be Paying Particular Attention To: Judges Will Be Paying Particular Attention To: • Career achievements and leadership qualities • Career achievements and leadership qualities • How the has CEO created value for shareholders and investors • How has the CEO created value for shareholders and investors • What the CEOs greatest achievements were in this period • What the CEOs greatest achievements were in this period • Creation of new partnerships / leveraging existing partnerships • Creation of new partnerships / leveraging existing partnerships • What the CEO has done to influence and advance the wider life • What the CEO has done to influence and advance the wider life science industry science industry

SUBMIT ENTRY SUBMIT ENTRY AWARDS AWARDS

Entrants must provide evidence - they should demonstrate the entry fits both the eligibility criteria and the required time frame. Nominations not fitting the Entering the European criteria or not meeting the minimum Lifestars Awards offers you an entrance requirements will be voided. unrivalled opportunity to gain Entry does not guarantee selection - acknowledgement and celebrate all regional champions will be informed the successes of your company, its personally as to their progress. employees and the wider life science industry. Entrants must be available to attend the awards ceremony - inability to It presents an opportunity to reward attend will void your application. and inspire and spur you and your

Confidentiality is key - only the ELA THE AWARDS team on to greater heights. management team and judges are WHY ENTER permitted to view the entries and supporting information. - Achieve peer recognition and gain external validation Judges are recruited based on their experience - they give up much of their - Become an awards winning business and raise company credibility time to review the entries provided and - Increase brand recognition and reputation through positive PR are not paid for their role. - Send a positive message to customers and prospects - Secure new investors and partners to grow your business - Benchmark against your industry peers and competitors - Attract ‘A’ grade talent and raise your hiring stature - Benefit from year round promotion and news flow - Network with executives from the year’s biggest success stories - Surround yourself with a service support network that has helped this year’s finalist roster

SUBMIT ENTRY If you have any questions about your eligibility to join the ELAs please contact us at [email protected] ELIGIBILITY Opportunities for Co-Host, Regional, TICKETS & Hospitality and Category-level partners to promote their brand, align their company with industry excellence and entertain and PACKAGES network with clients and valued prospects:

VIP Table Half Table Single Ticket Package Benefits CO-HOST PARTNER • The package for a company wishing to Corporate table branding Exclusive Joint No demonstrate industry-wide leadership

Priority Secondary Table location / allocated seating No priority REGIONAL PARTNER location location • The package for a company wishing to demonstrate its regional focus, Call for dinner First call Secondary call Final call experience and expertise.

Number of guest tickets 10 5 1 PARTNERSHIP HOSPITALITY PARTNER CORPORATE • The package for a company wishing to raise its company profile and educate Access to pre-ceremony 1.5hr reception Yes Yes Yes an engaged audience. The European Lifestars Awards CATEGORY PARNER Access to Charity Silent Auction Yes Yes Yes offers a number • The package for a company wishing to demonstrate its experience and of unique ways to Four-course dinner with wine Yes Yes Yes expertise in a specific service offering. raise your company

Evening entertainment Yes Yes Yes profile amongst the hundreds Whatever your corporate message, strategy or marketing outreach Awards ceremony proceedings Yes Yes Yes of executives attending the programme, there is a package for

Post-ceremony reception Yes Yes Yes evening ceremony you. and the thousands

Investment level £2,500+VAT £1,250+VAT £250+VAT of executives in Details of each of the four packages our community can be found in the pages that that will see the follow, but to request a callback to pre- and post- discuss any of these options, click event promotional [email protected]. TICKETS campaign. CORPORATE BRANDING LEVEL CORPORATE BRANDING LEVEL • Co-lead level branding on pre-event, on- • Secondary tier branding on the main pre-event, the-night and post-event AV, website and on-the-night and post-event AV, website and marketing materials. marketing materials. • Profile exclusivity at co-host level. • Profile exclusivity in your region of choice, • Double page advert in onsite ceremonial with prominent logo placement on all regional brochure. finalist’s website, online and on-the-night materials, plus the regional finalists dinner JUDGING FACULTY MEMBERSHIP tables. • 1 judging faculty member to nominate, review • Co-branding of the ‘region’ video backdrop

PARTNER and score in each of the 5 regions and all PARTNER where finalists are video interviewed after categories. collecting their award. • Single page advert in onsite ceremonial CATEGORY HOST AND brochure. WINNER PRESENTATION • An executive to announce the winner of one JUDGING FACULTY MEMBERSHIP CO-HOST category on stage and present the trophy with • 1 judging faculty member to nominate in your photo. allocated region. REGIONAL • Corporate logo placement on award trophy. • Same judging faculty member to review and score across all categories. REGION CHAMPION CO-HOST AND WINNER PRESENTATION CATEGORY HOST AND • An executive to join the onstage committee to WINNER PRESENTATION present medals to all finalists from the winning • An executive to announce the winner of one Co-host region. Regional category on stage and present the trophy with partnership is • On stage photo with region winners partnership photo. the highest level is the second • Corporate logo placement on award trophy. TABLE OF 10 GUESTS of partnership highest level • 2 tables of 10 guests will be allocated with front TABLE OF 10 GUESTS afforded at row table location and priority call for dinner. of partnership • 1 table of 10 guests will be allocated with front the European • 20% discount on all additional client tickets. afforded at row table location and priority call for dinner. Lifestars Awards. the European • 15% discount on all additional client tickets. LANYARD BRANDING Opportunities exist • Co-branding of category winner’s lanyards and Lifestars Awards. LANYARD BRANDING for one investment all non-finalist attendees. Opportunities exist • Co-branding of your allocated regional finalists bank, one global for a maximum of advisory, one law three co-hosts from firm, one exchange investment bank, and one pharma at global advisory, law this level. firm, exchange or pharma profiles. The package INVESTMENT INVESTMENT to demonstrate LEVEL £££££ LEVEL ££££ industry-wide leadership. CORPORATE BRANDING LEVEL CORPORATE BRANDING LEVEL • Second tier branding on all pre-event, on- • Third tier branding on all pre-event, on- the-night and post-event AV, website and the-night and post-event AV, website and marketing materials. marketing materials. • Exclusive logo placement in the reception • Single page advert in onsite ceremonial areas pre and post event ceremony as the sole brochure. Hospitality partner. • Single page advert in onsite ceremonial JUDGING FACULTY MEMBERSHIP brochure. • 1 judging faculty member to nominate in your allocated category.

PARTNER JUDGING FACULTY MEMBERSHIP PARTNER • Same judging faculty member to review and • 1 judging faculty member to nominate, review score across all categories. and score in each of the 5 regions and all categories. CATEGORY HOST AND WINNER PRESENTATION CATEGORY HOST AND • An executive to announce the winner of one WINNER PRESENTATION category on stage and present the trophy with • An executive to announce the winner of one photo. CATEGORY category on stage and present the trophy with • Corporate logo placement on award trophy. photo. • Corporate logo placement on award trophy. TABLE OF 10 GUESTS

HOSPITALITY • 1 table of 10 guests will be allocated with RECEPTION HOST standard table location. • Exclusive host of the pre-ceremony champagne • 10% discount on all additional client tickets. Hospitality reception, winners champagne and post- Award category partnership is the ceremony party. partnership is the second highest • Artistic license to theme the pre- and post- third highest level ceremony receptions. level of partnership of partnership afforded at TABLE OF 10 GUESTS afforded at the European • 1 table of 10 guests will be allocated with the European standard table location. Lifestars Awards. Lifestars Awards. • 15% discount on all additional client tickets. Opportunities exist Opportunities exist for all profiles to OFFICIAL CHARITY SELECTION for all profiles to • Align the Charity for the award donations with engage at this level. your own companies Charity engage at this level. The package for a The package for a company wishing company wishing to raise its company to demonstrate profile with an its experience engaged c-suite INVESTMENT and expertise in INVESTMENT audience. LEVEL ££££ a specific service LEVEL £££ offering. PARTNER PACKAGES

Package Benefits Co-Host Regional Hospitality Category

Corporate branding level Co-lead Second tier Second tier Third tier TO PARTNER TO 1 in all 5 1 in a region of 1 in a 1 in a category REASONS Judging faculty membership regions choice category of of choice choice Category host and winner presentation 1 category 1 category 1 category 1 category INFLUENCE Region Award co-host and winners Yes presentation -- Contribute to this year’s nomination process by referring clients / peers -- Participate in the judging faculty nomination process, providing your own votes alongside Table of 10 guests 2 tables 2 tables 1 table 1 table the external solicited nomination process.

-- Review this year’s award submissions, validate the finalist roster and participate in a final Co-branded winners lanyards Yes voting round to select this year’s winners and highly commended.

Co-branded All non-finalist -- Create a social buzz around this year’s finalists and promote the individuals, companies, regional Branded guest / finalists lanyards guests countries and regions to your network. finalists Advert in ceremonial brochure Double page Single page Single page Single page ENHANCE Pre/post ceremony reception host Yes -- Further elevate yourself as a key stakeholder in the industry and leverage your expertise to help determine this year’s winners. Branded winners champagne Yes -- Command a prominent place on 2020 official judging committee alongside peers and esteemed colleagues. Official Charity selection Yes -- Use the strength of the European Lifestars Awards brand and promotional machine to maximise yours and your company’s exposure and PR on an international stage. Discounted tickets for clients 20% 15% 15% 10%

Investment level £££££ ££££ ££££ £££ REAP

-- Network with executives from the year’s biggest success stories.

-- Join your industry’s biggest night of celebrations and corporate achievement. PARTNER -- Be part of the story that promote’s the best your industry has to offer. RIVERSIDE, 16LOWER THAMES ST, LONDON, EC3R 6DX 1 OLD BILLINGSGATE WALK, OLD BILLINGSGATE AWARDS VENUE View thevenue location onamap catch. 50 years ofice usedto store thefishermen’s Billingsgate, now The Vault, was covered in was themarket floor, andthebasementofOld events from exhibitions to awards dinners, 1982. The Grand Hall,whichnow holds varying a world famous fishmarket, runningupuntil This Victorian Grade IIlisted buildingwas once . Bridge, CityHall, andLondon Old Billingsgate offers unrivalled views of heritage. building that isaremarkable partofLondon’s the River Thames, stands astriking historic In theheartofCityonNorthbank

1

www.europeanlifestarsawards.com [email protected] +44 (0)207 039 3401 NEIL DARKES process andoffer someadvice would behappy to talkyou through the Get intouch withtheawards team who HELP WITHTHEPROCESS?

CONTACT